Montag & Associates’s Gildan GIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.55K Hold
30
﹤0.01% 891
2026
Q1
$1.67K Sell
30
-3
-9% -$194 ﹤0.01% 857
2025
Q4
$2.08K Sell
33
-10
-23% -$594 ﹤0.01% 861
2025
Q3
$2.51K Buy
43
+4
+10% +$214 ﹤0.01% 895
2025
Q2
$1.9K Hold
39
﹤0.01% 849
2025
Q1
$1.72K Hold
39
﹤0.01% 906
2024
Q4
$1.82K Hold
39
﹤0.01% 898
2024
Q3
$1.82K Sell
39
-1
-3% -$42 ﹤0.01% 924
2024
Q2
$1.52K Buy
40
+2
+5% +$72 ﹤0.01% 892
2024
Q1
$1.4K Buy
+38
New +$1.29K ﹤0.01% 896

Other funds holding GIL

Montag & Associates's GIL Position: Q2 2026 in Review

Montag & Associates held its Gildan (GIL) position steady in Q2 2026 at 30 shares worth $1.55K. The position accounts for ﹤0.01% of the portfolio, ranked #891.

Montag & Associates first reported a position in GIL in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.51K in Q3 2025. 459 funds tracked by Wall St. Rank hold GIL as of Q2 2026.

  • Montag & Associates held 30 shares of Gildan worth $1.55K as of Q2 2026.
  • Montag & Associates left its Gildan share count unchanged in Q2 2026.
  • Gildan made up ﹤0.01% of Montag & Associates's portfolio in Q2 2026, its #891 holding.
  • Montag & Associates first reported a position in Gildan in Q1 2024 and has held it in 10 quarters since.
  • Montag & Associates's Gildan position peaked at $2.51K in Q3 2025.
  • 459 funds tracked by Wall St. Rank held Gildan as of Q2 2026.

Based on Montag & Associates's 13F filing for Q2 2026, filed 5 Aug 2026.